Systems and methods for electrochemical marine alkalinity enhancement
The method and system for ocean alkalinity enhancement in electrochemical systems address scale formation issues by maintaining a specific pH and flow rate in bipolar membrane electrodialysis, enhancing alkalinity and reducing operational costs and complexity.
Patent Information
- Application Number
- JP2024538203
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2021-12-22
- Filing Date
- 2022-12-22
- Publication Date
- 2024-12-05
AI Technical Summary
Existing electrochemical systems for ocean alkalinity enhancement face issues with scale formation due to divalent cations, leading to higher energy consumption and membrane breakdown, which are typically addressed by expensive pre-treatments.
A method and system that bypasses the need for divalent cation removal by maintaining a specific pH range and flow rate in a bipolar membrane electrodialysis device, using a unique spacer configuration to prevent precipitation and enhance alkalinity without pre-treatment.
Achieves high-quality carbon removal at low cost by avoiding pre-treatment, improving ocean alkalinity and reducing operational complexity while extending membrane life.
Smart Images

Figure 2024545332000001_ABST
Abstract
Description
[Technical field]
[0001] This application claims priority to U.S. Provisional Patent Application No. 63 / 292,627, filed December 22, 2021, the entire contents of which are incorporated herein by reference.
[0002] The present disclosure relates to methods and systems for alkalinity enhancement of fluids such as brines, e.g., seawater, the results of which can be utilized for negative emission carbon removal, including returning the alkalinity-enhanced brine to the ocean to enhance the ocean's ability to remove carbon dioxide from the atmosphere and store it in dissolved ionic form (bicarbonate and carbonate ions). [Background technology]
[0003] Alkalinity enhancement of fluids such as brines includes electrochemical ocean alkalinity enhancement (OAE), which involves using electrochemistry to generate alkalinity that is then added to the ocean, thereby reducing ocean acidification, and the introduction of atmospheric CO into the ocean as bicarbonate. 2 Using the ocean to safely and continuously absorb atmospheric CO 2 Capturing carbon dioxide from ocean water is commonly referred to as marine carbon dioxide removal, or marine CDR.
[0004] Typically, these electrochemical systems take as input electricity and some brine stream (seawater, reverse osmosis concentrate, etc.), and the output is the component acids and bases of the incoming salts, e.g., NaCl in seawater is converted to HCl acid and NaOH base. Bipolar membrane electrodialysis (BPMED) is an electrochemical process that uses an ion-selective membrane between two end electrodes to produce HCl and NaOH from incoming NaCl-containing brine. The resulting NaOH and seawater are returned to the ocean, which improves ocean alkalinity and thus reduces ocean acidification, and reduces CO2 removal from the atmosphere. 2 Remove CO2 and safely return it to the ocean in dissolved ionic form (bicarbonate and carbonate)2 The oceans' capacity to store HCl is increased; the HCl produced can be sold commercially or stored as CO 2 It can be kept on land for other purposes, such as improving the reaction rate and storage capacity of mineralization reactors. Typically, the brine streams entering the BPMED, e.g., seawater or reverse osmosis concentrate, are calcium (Ca ++ ) and / or magnesium (Mg ++ ) divalent cations. These divalent cations increase with increasing pH, from CaCO 3 and / or Mg(OH) 2 Solid calcium and / or magnesium precipitates such as calcium ions, magnesium ions, and mercury ions can form. These precipitates can cause scale formation on the BPMED membrane, which in turn leads to higher energy consumption, shorter membrane life, and often the collapse of the BPMED operation. Traditionally, the problem of scale formation has been addressed by removing these divalent cations prior to BPMED, usually by pretreatment such as water softening. However, such pretreatment is expensive and adds complexity to the operation. Summary of the Invention [Problem to be solved by the invention]
[0005] Therefore, there is a need for a method and system for increasing the alkalinity of fluids, such as brines, without requiring removal of those divalent cations from the input stream to the BPMED. [Means for solving the problem]
[0006] In one aspect, the disclosure provides a method for improving alkalinity, comprising the steps of: (i) providing a bipolar membrane electrodialysis device (BPMED) including an electrode and at least one unit consisting of a brine compartment, an acid compartment, and a base compartment; and (ii) flowing an aqueous brine solution through the base compartment at a first volumetric flow rate (fba) and through the brine compartment at a second volumetric flow rate (fbr), the aqueous brine solution comprising at least one divalent cation that precipitates from the aqueous brine solution to form a solid precipitate when the aqueous brine solution is at or above a precipitation pH. (iii) applying a constant inter-electrode voltage to the BPMED device at a constant current density to form an enhanced alkaline brine product in the base compartment having a pH greater than the pH of the brine but less than the precipitation pH; (iv) maintaining a first volumetric flow rate through the base compartment at said current density sufficiently greater than a second volumetric flow rate through the brine compartment to maintain a pH of the enhanced alkaline brine product formed in the base compartment below the precipitation pH; and (v) outputting the enhanced alkaline brine product from the base compartment.
[0007] In another aspect, the present disclosure is directed to a system for improving alkalinity comprising a bipolar membrane electrodialysis device (BPMED) comprising a cathode and an anode, and at least one unit comprising a brine chamber comprising a first cation exchange membrane, a brine chamber spacer and an anion exchange membrane; a base chamber comprising a bipolar membrane, a base chamber spacer and a second cation exchange membrane; and an acid chamber located between the brine chamber and the base chamber and comprising an opposite side of the anion exchange membrane, an acid chamber spacer, and an opposite side of the bipolar membrane, wherein the base chamber spacer may be more rigid than the brine chamber spacer and the acid chamber spacer when the base chamber spacer is thicker than the brine chamber spacer and the acid chamber spacer.
[0008] In another aspect, the methods and systems disclosed herein provide electrochemical ocean alkalinity enhancement that produces very high quality “negative emission” carbon removal at low cost by avoiding pretreatment to remove precipitating divalent cations.
[0009] In one implementation, the flow-through design of the method and system provides pretreatment and Ca ++ and Mg ++ This allows the ability to feed seawater, or other aqueous brine solutions, such as reverse osmosis concentrate, directly into the brine and base compartments without the need for removal of divalent cations such as phosphate ions, phosphate ions, etc. [Brief description of the drawings]
[0010] [Figure 1] 1 is a schematic diagram of an embodiment of a method of the present disclosure and an embodiment of a BPMED system and method of the present disclosure. [Diagram 2] FIG. 2 is a schematic cross-sectional view of an embodiment of the BPMED system of FIG. [Figure 3A] FIG. 2 is a schematic perspective view of an embodiment of a base chamber spacer of the present disclosure. [Figure 3B] 3B is a schematic perspective view of the other side of the embodiment of the base chamber spacer of FIG. 3A. [Figure 3C] 1 is a schematic side view of another embodiment of a base chamber spacer of the present disclosure. FIG. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
[0011] The following detailed description of certain embodiments of the present disclosure is made with reference to the accompanying drawings, which are not intended to limit the scope of the present disclosure. In order to avoid obscuring the present invention with unnecessary details, descriptions of related functions or structures known in the art are omitted for the purpose of making it clear to understand the concept of the present invention.
[0012] As used herein, the term "about" indicates that the recited value may be somewhat modified as long as the modification does not result in incompatibility of the methods and systems described herein. For example, for some elements, the term "about" may refer to a variation of ±0.1%, while for other elements, the term "about" may refer to a variation of ±1% to ±10%, or any point therebetween. As used herein, the terms "substantially" or "substantially" are equally applicable when used in the negative sense and refer to a perfect or nearly perfect action, feature, characteristic, state, structure, article, or result. For example, a surface that is "substantially" flat is completely flat, or nearly flat enough that the effect would be the same as if the surface were completely flat. Reference to any numerical range as used herein expressly includes each numerical value (including decimals and integers) encompassed by the range, including the endpoints of the range. For purposes of example only, reference to a range "0.0001 to 5000" includes integers such as 5000, 4999, 4998...3, 2, 1, etc., and includes decimals such as 0.00011, 0.00012...0.1, 0.2, 0.3...1.1, 1.2, 1.3....100.5, 100.6...4900.5, 4990.6, 4990.7, etc.
[0013] Embodiments of the systems and methods described herein provide bipolar membrane electrodialysis systems and methods that are specifically configured to avoid the removal of divalent cations prior to inputting the stream into a bipolar membrane electrodialysis unit and to take a brine containing divalent cations as an input.
[0014] A schematic diagram of a method and system for improving the alkalinity of an aqueous brine solution is illustrated in Figure 1, where the term aqueous brine solution as used herein includes, but is not limited to, salt water such as seawater, brackish water, brine obtained from a desalination process, or mined salts such as, for example, bicarbonates and / or carbonates of sodium and / or potassium that are dissolved to produce the brine solution. Figure 1 (and Figure 2) shows a bipolar membrane electrodialysis device (labeled BPMED) with a cathode and an anode, where the BPMED includes at least one acid compartment, a brine compartment, and a base compartment in the embodiment shown from left to right (Figure 2). In the implementation shown in FIG. 1 , the input to the brine chamber ("brine input") and the input to the base chamber ("base chamber") are the same, i.e., both inputs are from the same brine source, such as some form of aqueous brine stream, possibly from seawater (having a salinity of about 35) from the ocean or reverse osmosis concentrated brine (having a salinity of about 70) which may come from a desalination plant, or the brine source may be from some other brine stream or process. In one implementation, the brine source is the ocean and the enhanced alkalinity brine product stream is returned to the ocean to mitigate ocean acidification. In one embodiment, the enhanced alkalinity brine product stream is combined with the partially desalinated brine output stream for return to the ocean.
[0015] 1 shows the brine and base inputs at a pH of 8.1, the pH of either or both inputs can range from pH 6 to 8.5. Traditionally, the brine and base input streams, such as seawater or reverse osmosis concentrate, have had to be pretreated to remove divalent cations, for example calcium (Ca++) and / or magnesium (Mg++), because the presence of these cations at the high pH values typically encountered in the base compartment of a BPMED unit, e.g., around pH 14, can result in the formation of solid Mg(OH) ions on the membranes within the BPMED. 2 and CaCO 3This would result in precipitation of divalent cations, which would then cause the BPMED to perform significantly less well. In the flow-through system and method illustrated in FIG. 1, removal of these types of divalent cations is not performed or required, because the volumetric flow rate (f BA ) maintains the maximum pH in the base chamber (measured by the base chamber output) in the range of 8.5 to 8.9, the more the OH concentration is reduced due to the applied current density when a certain voltage is applied between the electrodes. - The 8.5 to 8.9 range is large enough for the movement of ions, so Mg(OH) 2 Solid and CaCO 3 This is below the pH at which precipitation of solids as well as other solids occurs, thereby eliminating the need to remove the associated divalent cations. For a typical operating value of current density, this is calculated by multiplying the volumetric flow rate through the base compartment by the volumetric flow rate through the brine compartment (f BR ), i.e., f BA >f BR 1, so that the pH of the enhanced alkaline brine product produced in the base compartment remains below the precipitation pH. This can also be achieved by keeping the current density low enough at a given volumetric flow rate through the base compartment to keep the pH in the base compartment below the precipitation threshold.
[0016] In the flow-through configuration shown in FIG. 1, the acid stream is a "feed and bleed" configuration. As shown, the concentration of the aqueous acid input to the acid chamber channel is constant and is labeled X% HC1. After flowing through the acid chamber of the BPMED unit, the output acid concentration rises to (X+ε)% HC1 (denoted as "more concentrated acid output"). In the implementation shown, there is then a bleed-off of a portion of this (X+ε)% HC1 higher concentration product acid. The rate at which the higher concentration acid is bled off matches the feed rate of deionized water (DI water), such a configuration resulting in a constant concentration of X% HC1 at the acid input. Although "DI water" is illustrated in FIG. 1, this feed may be an aqueous brine solution such as seawater, or other aqueous solution where the product is HC1 in brine, e.g., seawater, or other aqueous solution rather than DI water. The HC1 bled off at a concentration of (X+ε)% HC1 may be used for commercial sale or CO2 emission. 2 It can be recovered for other uses, including improving the reaction rates and storage capacity of mineralization reactors.
[0017] 2, there is shown a schematic cross-sectional view of an embodiment of a BPMED system useful in FIG. 1, which shows an electrodialysis unit 100 including at least one cell triplet (cell 1) including a brine compartment 210, an acid compartment 220, and a base compartment 230, but which may include a plurality of "N" such cell triplets in series, for example up to 100 cells or more, with the illustrated configuration having each triplet in series with a brine compartment 210, 210A...up to 200N, and an acid compartment 220, 220A...200N (none shown). The unit 100 includes a cathode 110 and an anode 114, where each electrode compartment 200 and 116 has an end cap membrane 118 and 120 that separates the electrode compartments from the BPMED membrane cell and each may individually include a sulfonated tetrafluoroethylene-based fluoropolymer-copolymer commercially available as Nafion®. The electrodes 110 and 114 may comprise materials known in the art, such as nickel. In that such membranes are adjacent to the respective electrodes as depicted in FIG. 2, it is understood that multiple configurations are possible and that the configuration depicted in FIG. 2 is merely representative in this respect. In one implementation, an electrode solution, such as an aqueous sodium hydroxide (NaOH) solution, is flowed through the electrode chambers 200 and 116; in this implementation, the positively charged electrode 114 will cause sodium ions (Na+) to migrate across the end cap membrane 120 and the negatively charged electrode 110 will attract sodium ions to the electrode chamber 200. Other suitable electrode solutions include sodium sulfate adjusted to be acidic by the addition of sulfuric acid or sodium sulfate adjusted to be basic by the addition of sodium hydroxide.
[0018] In the embodiment shown in Figure 2, the brine compartment 210 is defined by a cation exchange membrane (CEM) 130 and an anion exchange membrane (AEM) 150 (when these or other elements of the BPMED are present in multiples and in series, the membranes are designated with a letter suffix, e.g., 130, 130A...130N; 150, 150A...150N, etc.). Useful CEMs include monovalent cation permselective membranes known in the art, such as, but not limited to, those commercially available as Neosepta CMX-S. Useful AEMs include monovalent anion permselective membranes known in the art, such as, but not limited to, those commercially available as Neosepta ACS. The brine chamber 210 also includes a brine chamber spacer 140, which may include spacers known in the art, polymers such as polyolefins, including polypropylene, or silicone compounds, may be woven or nonwoven, may be the same or similar in outer dimensions as the CEM 130 and AEM 150, and may have a thickness of about 0.15 to about 1.5 mm. The acid chamber 220 is defined by the opposing side of the AEM 150 and by a bipolar membrane (BPM) 170. Practical BPMs for use herein include those known in the art, such as, but not limited to, those commercially available as Neosepta BP-1E. The acid chamber 220 also includes an acid chamber spacer 160, which may include the same material of construction and size as the base chamber spacer 140; in one implementation, the base chamber spacer and the acid chamber spacer are substantially identical, thereby avoiding or minimizing hydrostatic pressure differences that would otherwise occur across the membrane due to volumetric flow rates through adjacent chambers. Overall, when a voltage is applied across the unit 100 by the electrodes 110, 114, dissociation of water inside the BPM causes hydrogen ions (H + ) and hydroxide ions (OH - ) transport. With respect to AEM / CEM, AEM / CEM allow the transport of negatively / positively charged ions through the membrane.
[0019] The base chamber 230 is defined by the opposite side of the BPM 170 and the opposite side of the CEM 130A. The cation exchange membrane 130A may be different from the CEM 130, or preferably the same. In one embodiment, the base chamber spacer 180 is more rigid than the brine chamber spacer 140 and the acid chamber spacer 160. This is to minimize or prevent undesirable hydrostatic pressure differences when the BPMED is in operation. In one embodiment, the side of the base chamber spacer 180 close to the bipolar membrane 170 is configured to be more rigid than the side of the base chamber spacer 180 facing the bipolar membrane 170, e.g., by including a more rigid backing on that side compared to the interior of the spacer 180. Additionally, or alternatively, the base chamber spacer 180 can have a thickness greater than that of the brine chamber spacer 140, and greater than that of the acid chamber spacer 160; for example, the base chamber spacer 180 can be up to 10 times thicker than the brine chamber spacer 140 and the acid chamber spacer 160, although the spacers 140 and 160 can have the same thickness. The base chamber spacer 180 can include a woven polyolefin, such as polypropylene, or silicone, and can be configured as a mesh. Various base chamber spacer embodiments are illustrated in FIG. 3.
[0020] Operationally, in one non-limiting implementation and with reference to FIG. 1 , an aqueous brine solution flows through the base chamber 230 at a first volumetric flow rate (fba) (base in) and through the brine chamber 210 at a second volumetric flow rate (fbr) (brine in). The aqueous brine solution includes at least one divalent cation that precipitates from the aqueous brine solution to form a solid precipitate when the aqueous brine solution is at or above a precipitation pH; an exemplary divalent cation is calcium (Ca ++ ), Magnesium (Mg ++ ) or both; typical solid precipitates include CaCO 3 , Mg(OH) 2or both. Such presence of divalent cations of Ca and Mg can occur naturally, such as in seawater and brackish water. The aqueous brine solution (brine input) flowing to the brine chamber 210 can be the same or different from the aqueous brine solution (base input) flowing to the base chamber 220, e.g., seawater, reverse osmosis concentrated brine, etc.; each of the brine input and base input can be from the same or different brine sources, e.g., natural seawater (such as the ocean) or a source containing mined salts that are dissolved to produce the aqueous brine solution. The aqueous brine solutions can flow in separate lines from the brine source to each of the brine chambers and / or base chambers 210, 230, or in a common line that branches and feeds each of the brine and base chambers 210, 230, as shown in FIG. 1.
[0021] A constant voltage is applied between electrodes 110 and 114, which voltage provides a constant current density to the BPMED 100 such that an enhanced alkaline brine product is formed in the base compartment 230 (and base compartments 230A...230N, if cells in series are used, as understood herein), the enhanced alkaline brine product having a pH greater than the pH of the aqueous brine solution feed (base input) but less than the precipitation pH of the aqueous brine solution feed containing one or more divalent cations. One embodiment for doing this includes maintaining a first volumetric flow rate (fba) through the base compartment 230 at the current density sufficiently greater than a second volumetric flow rate (fbr) through the brine compartment 210 to maintain the pH of the enhanced alkaline brine product formed in the base compartment 230 below the precipitation pH. In one implementation, the first volumetric flow rate (fba) through the base compartment 230 is about 1 to about 10 times the second volumetric flow rate (fbr) through the brine compartment 210. As shown in FIG. 2, the brine compartment 210, the acid compartment 220, and the base compartment 230 are contained in a cell triplet (cell 1 triplet); in one implementation, the BPMED 100 includes multiple cell triplets in series (cell 1 triplet...cell N triplet (not shown)). In one embodiment, the voltage and current density applied between the electrodes to perform the above alkalinity improvement is about 1 V to about 4 V per cell triplet, with a current density of about 5 mA / cm. 2 ~Approx. 120mA / cm 2 In one embodiment, the voltage is used as an early indicator to signal the need for a rapid clean-in-place by flushing some of the generated acid 510 or 540 through all of the chambers; the pH of the output during this cleaning process can be used to improve the voltage feedback signal.
[0022] Without being limited thereto, typical values of pH of the aqueous brine solution feed for the brine input 400 (and brine inputs 400A...400N for cells in series, not shown) and for the base input 410 (and base inputs 410A...410N for cells in series) are between about 6 and about 8.5, e.g., pH 8.1. A typical precipitation pH of the aqueous brine solution feed input containing divalent cations of calcium and / or magnesium can be as high as pH 14, e.g., pH 9 or higher. Without being limited thereto, typical values of pH of the partially desalted brine output 420 (420A...420N for cells in series) from the brine chamber 210 (210A...210N for cells in series, not shown), the same as the input 410, are between about 6 and about 8.5. Typical values for the enhanced alkaline brine product 430A (up to 430N) output from the base compartment 230 (230A...230N for cells in series) are between about 8.5 and about 8.9. In one implementation, the first volumetric flow rate (fba) through the base compartment 230 compared to the current density is such that the pH of the base compartment 230 does not exceed 8.5.
[0023] In one embodiment (not shown), at least a portion of the enhanced alkaline brine product 430A output from the base chamber 230 is flowed directly to the final destination 300, which may include a seawater body, e.g., the ocean, or with other processing. In another embodiment, illustrated in Figure 2, some or all of the partially desalted brine product 420 formed in and output from the brine chamber 210 is combined with all or at least a portion of the enhanced alkaline brine product 430A output from the base chamber 230, and the combined stream is flowed to the final destination 300, e.g., the ocean. In one embodiment (not shown), some or all of the partially desalted brine product 420 formed in and output from the brine chamber 210 constitutes all or a portion of the feed 410 (base input) to the base chamber 230.
[0024] As shown in FIG. 2, an aqueous stream 500 containing a first concentration of HCl (X% HCl) is passed to the acid chamber 220, and an acidification product 510 having a second concentration of HCl greater than the first concentration, denoted as (X+ε)% HCl, where ε represents the increase in concentration, is generated in the acid chamber and output therefrom. In one embodiment, a portion of the acidification product stream 510 is bled off as 520. A water stream 310, which may include deionized water or an aqueous brine solution, is fed to a stream 530 containing the acidification product at a concentration of (X+ε)% HCl that was not bled off at a rate and amount sufficient to form a stream 540 having a first concentration of X% HC1, which then supplies the acid input feed 500 to the acid chamber 220. Of course, if the BPMED unit 100 includes multiple cell triplets, this feed and bleed technique can be applied to all acid chambers 220 (up to 200N, not shown). In one implementation, a first portion of stream 540 is recovered as an HCl product having an HCl concentration of about 0.1 M to about 1 M; a second portion of stream 540 is passed to acid chamber 220 as an acid input feed. In another embodiment, bleed-off stream 520 containing a second concentration of (X+ε)% HCl is recovered as a product or recovered and utilized as a feed to another process.
[0025] In another embodiment of the present disclosure shown in Figure 2, the system for improving alkalinity includes a bipolar membrane electrodialysis device (BPMED) 100, which includes a cathode 110 and an anode 114, and at least one unit, or cell triplet, including a brine compartment 210 including a first cation exchange membrane 130, a brine compartment spacer 140, and an anion exchange membrane 150; a base compartment 230 including a bipolar membrane 170, a base compartment spacer 180, and a second cation exchange membrane 130A; and an acid compartment 220 located between the brine compartment 210 and the base compartment 230 and including an opposite side of the anion exchange membrane 150, an acid compartment spacer 160, and an opposite side of the bipolar membrane 170. In one implementation, as shown in Figure 2, the acid compartment 220, the brine compartment 210, and the base compartment 230 each include an individual inlet and outlet, and each are individually configured for flow-through operation. The system shown in Figure 2 can further include one or more flow controllers (not shown) known in the art to maintain a volumetric flow rate through the base compartment at a greater amount than the volumetric flow rate through the brine compartment. The BPMES of the system can include one or more cell triplets in series.
[0026] The base chamber spacer 180 is as rigid as or more rigid than the brine chamber spacer 140 and / or the acid chamber spacer 160. In one implementation, the basic side of the base chamber spacer 180 proximal to the bipolar membrane 170 is configured to be more rigid than the side of the base chamber spacer opposite the bipolar membrane, such that the base chamber spacer is more rigid than the brine chamber spacer 140 and the acid chamber spacer 160. Additionally or alternatively, the base chamber spacer 180 has a thickness that is greater than the thickness of the brine chamber spacer 140 and greater than the thickness of the acid chamber spacer 160. In this regard, the acid chamber spacer 160 and the brine chamber spacer 160 may have the same thickness or different thicknesses. A typical thickness of each of the acid chamber spacer 160 and the brine chamber spacer 140 is between about 0.5 and about 1.2 mm. In one implementation, the base chamber spacer 180 has a thickness up to 10 times the thickness of the acid chamber spacer and the brine chamber spacer. Without being limited thereto, the base chamber spacer 180 can include a woven polypropylene or silicone mesh.
[0027] 3A, 3B, and 3C, there are illustrated embodiments of spacers useful as base chamber spacers. In FIGS. 3A and 3B, spacer 700 includes a first side 730 and a second side 750 opposite the first side. As shown, spacer 700 is substantially rectangular, with a first end 770 and a second end 780, although other shapes are contemplated. The spacer may also include through holes 710 and / or 720 to allow fluid flow within the respective chambers. In one implementation, first side 730 has a first mesh pattern 740 and second side 750 has a second mesh pattern 760, with at least a portion of the openings in first mesh pattern 740 having a larger open area than the open area of second mesh pattern 760, which as shown has a denser, tighter mesh. The openings of the first mesh pattern 740 may be uniform or non-uniform across the first side 730. In one embodiment, the larger open area and mesh design of the first mesh pattern 740 is configured to eliminate non-uniform high pH hot spots near the spacer membrane surface. In one embodiment, the openings of the first mesh pattern 740 are configured to provide less fluid resistance than the openings of the second mesh pattern 760. In one implementation, the openings of the first mesh pattern 740 are larger toward the first end 770. The first and second mesh patterns 740, 760 can each individually comprise a woven polymer mesh, for example from a polyolefin such as polypropylene or a silicone mesh. The woven mesh can be in an overlapping or non-overlapping pattern. In FIG. 3C, there is another embodiment of a spacer 600 for use with a base chamber. Spacer 600 may include a mesh as previously described, a first side 650 and a second side 620, and includes a body 610 including a rigid backing 630 on top of the first side 650; the rigid backing may be integral with the first side or may be adhered thereto. The rigid backing 630 is also near the membrane surface (not shown) and may be more rigid compared to the interior of the spacer.As shown, the rigid backing 630 defines a surface 640 that will be positioned adjacent to the bipolar membrane when used in the base compartment of the BPMED. The rigid backing can be used in conjunction with the open mesh embodiment of Figures 3A and 3B. In another implementation, the spacer 600 defines a thickness T that is up to 10 times the thickness of the corresponding spacers used in the brine and acid compartments of the BPMED. Without limitation, the thickness T can range from about 2 mm to about 12 mm. EXAMPLES
[0028] Preliminary testing was performed to demonstrate that maintaining the pH of the base compartment below 8.7 prevents precipitation of solids inside the BPMED system, even in the presence of divalent ions such as Ca++ and Mg++. The BPMED system included an acid tank, a base tank, and a brine tank, and was run in batch mode. The input to the BPMED was led from these tanks, routed through their respective paths in the BPMED system, and then returned to the same tanks. In batch mode, the acid continues to become more acidic over time, the base continues to become more basic over time, and the brine continues to become less saline over time. Table 1 below shows the data from this testing. The starting solutions were 0.5M NaCl in the acid and brine compartments, and 0.5M "Instant Ocean" in the base compartment. Instant Ocean is a commercially available salt mixture designed to mimic seawater, containing divalent cations such as Ca++ and Mg++ in approximately the same concentrations as seawater. Each row below represents the current and voltage measured by the BPMED system during a 10 second interval when current was applied. During these times, the acid, brine and base solutions continued to flow but no current was applied. This allowed each tank to mix thoroughly after current was applied, resulting in a uniform pH in each tank. The pH values listed are those after the pH had stabilized. An indication of the onset of precipitation in the system is that at a given current density, the voltage begins to rise due to the formation of a solid precipitate on the membrane. The data below shows that the voltage remained constant at a constant current value for 110 minutes while being exposed to pH values up to 8.69 in the base compartment, despite the fact that the base solution was seawater without the removal of divalent cations. These data indicate that by keeping the pH low enough as in the present invention for the flow through, seawater can be used without the need for pretreatment.
[0029] [Table 1] [Explanation of symbols]
[0030] 100 Electrodialysis Units / Bipolar Membrane Electrodialysis Devices (BPMED) 110 Cathode 114 Anode 116 Electrode chamber 118 End Cap Membrane 120 End cap membrane 130 Cation Exchange Membrane (CEM) / First Cation Exchange Membrane 130A Second cation exchange membrane 140 Brine chamber spacer 150 Anion Exchange Membrane (AEM) 160 Acid chamber spacer 170 Bipolar Membrane (BPM) 180 Base Chamber Spacer 200 Electrode chamber 210 Brine Room 220 Acid chamber 230 Base Room 300 final destination 310 A water stream that may contain deionized water or an aqueous brine solution 400 Brine Input 410 Base input / supply to base chamber 230 420 Partially desalted brine output / Partially desalted brine product 430 Improved Alkaline Brine Production 500 Aqueous flow containing a first concentration of HCl (X% HCl) / acid input feed 510 Produced Acid / Acidification Product / Acidification Product Stream 520 A portion of the acidified product stream / bleed-off stream containing a second concentration of (X+C)% HCl 530 Stream containing acidification products at concentration (X+C)% HC1 that was not bled off 540 generated acid / stream having first concentration X% HC1 / stream supplying acid input feed 500 to acid chamber 220 600 Spacer 610 Main unit 620 Second Aspect 630 Rigid Backing 640 Surface to be placed adjacent to the bipolar membrane 650 First Aspect 700 Spacer 710 Through hole 720 Through hole 730 First Aspect 740 First Mesh Pattern 750 Second Aspect 760 Second Mesh Pattern 770 First End 780 Second End
Claims
1. 1. A method for increasing alkalinity, comprising: (i) providing a bipolar membrane electrodialysis device (BPMED) including electrodes and at least one unit consisting of a brine compartment, an acid compartment, and a base compartment; (ii) flowing an aqueous brine solution through the base compartment at a first volumetric flow rate (fba) and through the brine compartment at a second volumetric flow rate (fbr), the aqueous brine solution comprising at least one divalent cation that precipitates from the aqueous brine solution to form a solid precipitate when the aqueous brine solution is at or above a precipitation pH; (iii) applying a constant interelectrode voltage at a constant current density to the BPMED device to form an enhanced alkaline brine product in the base compartment having a pH greater than the pH of the brine but less than the precipitation pH; (iv) maintaining a first volumetric flow rate through the base compartment at said current density sufficiently greater than a second volumetric flow rate through the brine compartment to maintain a pH of an enhanced alkaline brine product formed in the base compartment below a precipitation pH; (v) outputting the enhanced alkaline brine product from the base compartment; A method comprising:
2. 2. The method of claim 1, wherein the aqueous brine solution flowing into the base compartment and flowing into the brine compartment is from a brine source, which may be the same or a different source for each of the base compartment and the brine compartment, respectively.
3. 3. The method of claim 2, wherein the aqueous brine solution is flowed from the brine source directly into the base compartment, directly into the brine compartment, or directly into both.
4. 10. The method of claim 1, wherein the aqueous brine solution comprises seawater, reverse osmosis concentrated brine, or both.
5. 3. The method of claim 2, wherein the brine source is natural seawater or mined salt that is dissolved to produce an aqueous brine solution.
6. The divalent cation is selected from calcium (Ca), magnesium (Mg) or both divalent cations, and the precipitate is CaCO 3 Or Mg(OH) 2 Or both.
7. 10. The method of claim 1, wherein the brine pH is from about 6 to about 8.5, the precipitation pH is about 8.9 or greater, and the pH of the improved alkaline brine product is from about 8.5 to about 8.
9.
8. The method of claim 1 , wherein the first volumetric flow rate is from about 1 to about 10 times the second volumetric flow rate.
9. 10. The method of claim 1, wherein at least a portion of the enhanced alkalinity brine product output from the base chamber is channeled into a seawater body.
10. 10. The method of claim 1, wherein a partially desalted brine product is formed in and output from the brine compartment, and at least a portion of the desalted brine product output from the brine compartment is combined with at least a portion of the enhanced alkalinity brine product output from the base compartment.
11. 10. The method of claim 1, wherein a partially desalted brine product is formed in and output from the brine compartment, and at least a portion of the desalted brine product output from the brine compartment is input to the base compartment.
12. 11. The method of claim 10, wherein the combination of the partially desalted brine product and the improved alkalinity brine product is discharged to a seawater body.
13. 11. The method of claim 10, wherein the desalted brine product output from the brine chamber has a pH of about 8.5 or less, and the pH of the combined desalted brine product and improved alkalinity brine product is from about 8.1 to about 8.
9.
14. The brine, acid and base compartments are contained in a cell triplet, the BPMED includes a plurality of cell triplets in series, the voltage applied between the electrodes is about 1 V to about 4 V per cell triplet, and the current density is about 5 mA / cm 2 ~Approx. 120mA / cm 2 The method of claim 1, wherein
15. 2. The method of claim 1, wherein an aqueous stream having a first concentration of HCl is flowed into an acid compartment, and an acidification product having a second concentration of HCl greater than the first concentration is formed in and output from the acid compartment.
16. 16. The method of claim 15, wherein the aqueous stream comprises a combination of at least a portion of the acidification product output from the acid chamber and the water feed.
17. 17. The method of claim 16, wherein the water supply comprises deionized water or brine.
18. 17. The method of claim 16, wherein a first portion of the aqueous stream is recovered as an HCl product having an HCl concentration of about 0.1 M to about 1 M, and a second portion of the aqueous stream is passed to the acid chamber.
19. 1. A system for improving alkalinity comprising a bipolar membrane electrodialysis device (BPMED), the bipolar membrane electrodialysis device (BPMED) comprising: a cathode and an anode; At least one unit, a brine chamber including a first cation exchange membrane, a brine chamber spacer, and an anion exchange membrane; a base chamber including a bipolar membrane, a base chamber spacer and a second cation exchange membrane; and an acid chamber located between the brine chamber and the base chamber and including an opposite side of the anion exchange membrane, an acid chamber spacer, and an opposite side of the bipolar membrane; Including, the base compartment spacer is as rigid as or more rigid than the brine and acid compartment spacers; At least one unit; Including, the system.
20. 20. The system of claim 19, wherein a side of the base chamber spacer closer to the bipolar membrane is configured to be stiffer than a side of the base chamber spacer opposite the bipolar membrane.
21. 20. The system of claim 19, wherein the base chamber spacer has a thickness greater than a thickness of the brine chamber spacer and greater than a thickness of the acid chamber spacer.
22. 22. The system of claim 21, wherein the acid chamber spacer and the brine chamber spacer have the same thickness.
23. 23. The system of claim 22, wherein the acid chamber spacer and the brine chamber spacer each have a thickness between about 0.15 and about 1.5 mm.
24. 23. The system of claim 22, wherein the base chamber spacer is up to 10 times the thickness of the acid chamber spacer and the brine chamber spacer.
25. 20. The system of claim 19, wherein the base chamber spacer comprises a woven polypropylene or silicone mesh.
26. 20. The system of claim 19, wherein the acid compartment, the brine compartment and the base compartment each include a separate inlet and outlet and each are each individually configured for flow-through operation.
27. 20. The system of claim 19, further comprising a flow controller to maintain a volumetric flow rate through the base compartment at a greater amount than a volumetric flow rate through the brine compartment.
28. 20. The system of claim 19, wherein the brine compartment, the acid compartment and the base compartment are contained in a cell triplet, and the BPMED comprises a plurality of cell triplets in series.
29. 1. A spacer for a bipolar membrane electrodialysis device (BPMED) comprising a first side and a second side, wherein: (i) the first side comprises a first mesh pattern and a second side opposite the first side comprises a second mesh pattern, at least a portion of the openings of the first mesh pattern having an open area greater than the open area of the second mesh pattern, or (ii) the first side comprises a rigid backing on an upper surface of the first side, or (iii) both (i) and (ii).
30. 30. The spacer of claim 29, wherein the openings of the first mesh pattern are configured to provide less fluid resistance than the openings of the second mesh pattern.
31. 30. The spacer of claim 29, wherein the spacer is substantially rectangular and includes an upper end and a lower end, the openings of the first mesh pattern becoming larger towards the first end.
32. 30. The spacer of claim 29, wherein the openings of the first mesh pattern are not uniform across the first side.
33. 30. The spacer of claim 29, wherein the first and second mesh patterns each individually comprise a woven polymer.
34. 34. The spacer of claim 33, wherein the woven polymer comprises a non-overlapping pattern.
35. 30. The spacer of claim 29, wherein the rigid backing is integral with or adhered to the first side.
